Synergy Pharmaceuticals Company Profile (NASDAQ:SGYP)

About Synergy Pharmaceuticals

Synergy Pharmaceuticals logoSynergy Pharmaceuticals Inc. (Synergy) is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's GI platform includes two lead product candidates: plecanatide and dolcanatide. It is engaged in the discovery, research and development involving uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Plecanatide is the Company's uroguanylin analog being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change. Dolcanatide is also its uroguanylin analog being explored for inflammatory bowel disease (IBD). Dolcanatide is designed to be an analog of uroguanylin with resistance to standard digestive breakdown by proteases in the intestine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGYP
  • CUSIP: 87163930
Key Metrics:
  • Previous Close: $5.31
  • 50 Day Moving Average: $5.13
  • 200 Day Moving Average: $3.91
  • 52-Week Range: $2.50 - $7.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.97
  • P/E Growth: 0.00
  • Market Cap: $952.86M
  • Outstanding Shares: 179,446,000
  • Beta: 696.01
Profitability:
  • Return on Assets: -104.56%
Debt:
  • Debt-to-Equity Ratio: 1.60%
  • Current Ratio: 6.29%
  • Quick Ratio: 6.29%
Additional Links:
Companies Related to Synergy Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Synergy Pharmaceuticals (NASDAQ:SGYP) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $10.75 (102.45% upside)

Analysts' Ratings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Show:
DateFirmActionRatingPrice TargetDetails
9/16/2016BTIG ResearchReiterated RatingBuy$11.00View Rating Details
9/8/2016HC WainwrightSet Price TargetBuy$15.00View Rating Details
9/8/2016Rodman & RenshawReiterated RatingBuy$15.00View Rating Details
7/17/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details
5/26/2016Roth CapitalReiterated RatingBuy$6.50View Rating Details
3/16/2016Citigroup Inc.Lower Price TargetNeutral$7.00 -> $4.00View Rating Details
6/18/2015Cantor FitzgeraldReiterated RatingBuy$8.50 -> $14.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/8/2016Q216($0.20)($0.23)ViewN/AView Earnings Details
5/10/2016Q1($0.23)($0.51)ViewN/AView Earnings Details
11/9/2015Q315($0.28)($0.23)ViewN/AView Earnings Details
8/10/2015Q215($0.28)($0.34)$102.00 millionViewN/AView Earnings Details
5/11/2015Q115($0.33)($0.28)ViewN/AView Earnings Details
3/16/2015($0.28)($0.32)ViewN/AView Earnings Details
11/10/2014($0.28)($0.24)ViewN/AView Earnings Details
8/11/2014($0.23)($0.28)ViewN/AView Earnings Details
5/13/2014Q114($0.23)($0.18)ViewN/AView Earnings Details
3/17/2014Q4 13($0.20)($0.22)ViewN/AView Earnings Details
11/12/2013Q3($0.17)($0.15)ViewN/AView Earnings Details
11/13/2012Q312($0.01)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Synergy Pharmaceuticals (NASDAQ:SGYP)
Current Year EPS Consensus Estimate: $-0.83 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.19)($0.19)($0.19)
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.25)($0.25)($0.25)
Q4 20161($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Synergy Pharmaceuticals (NASDAQ:SGYP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 56.67%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/28/2016Paulson & Co. Inc.Major ShareholderSell54,300$5.69$308,967.00View SEC Filing  
9/19/2016John P BrancaccioDirectorSell2,518$5.76$14,503.68View SEC Filing  
9/19/2016Paulson & Co. Inc.Major ShareholderSell3,473,713$5.61$19,487,529.93View SEC Filing  
9/14/2015Bernard DenoyerSVPSell10,000$7.50$75,000.00View SEC Filing  
9/11/2015Alan JoslynDirectorSell13,754$7.22$99,303.88View SEC Filing  
6/3/2014John P BrancaccioDirectorBuy3,500$4.12$14,420.00View SEC Filing  
5/27/2014Gary S JacobCEOBuy4,000$4.18$16,720.00View SEC Filing  
5/23/2014Bernard DenoyerSVPBuy2,500$3.89$9,725.00View SEC Filing  
5/23/2014Kunwar ShailubhaiInsiderBuy3,000$3.89$11,670.00View SEC Filing  
10/29/2013Gabriel CerroneDirectorBuy12,000$4.09$49,080.00View SEC Filing  
6/21/2013Bernard DenoyerSVPBuy7,500$4.78$35,850.00View SEC Filing  
6/14/2013Gabriel CerroneChairmanBuy8,000$4.42$35,360.00View SEC Filing  
4/24/2013Gabriel CerroneChairmanBuy5,500$4.66$25,630.00View SEC Filing  
2/5/2013Gabriel CerroneChairmanBuy5,000$6.15$30,750.00View SEC Filing  
2/4/2013Gabriel CerroneChairmanBuy13,090$6.04$79,063.60View SEC Filing  
1/30/2013Gabriel CerroneChairmanBuy26,000$5.98$155,480.00View SEC Filing  
11/14/2012Gabriel CerroneChairmanBuy87,820$3.61$317,030.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateHeadline
streetinsider.com logoSynergy Pharma (SGYP) Will Present New Plecanatide Data in CIC ... - StreetInsider.com (NASDAQ:SGYP)
www.streetinsider.com - September 29 at 12:43 PM
News IconTeva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) & Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Watch List - Money News (NASDAQ:SGYP)
www.newsismoney.com - September 29 at 12:43 PM
streetinsider.com logoSynergy Pharma (SGYP) Will Present New Plecanatide Data in CIC, IBS-C at ACG Meeting (NASDAQ:SGYP)
www.streetinsider.com - September 28 at 12:31 PM
News IconSynergy Pharmaceuticals Announces New Plecanatide Data Presentations at Upcoming Scientific Meeting & Provides Update on IBS-... (NASDAQ:SGYP)
ih.advfn.com - September 28 at 12:31 PM
News IconStock's Buzz: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), 3D Systems Corporation (NYSE:DDD) - Newburgh Press (NASDAQ:SGYP)
newburghpress.com - September 27 at 11:53 AM
News IconTwo Biotechnology Names Are Hot: UnitedHealth Group Incorporated (UNH), Synergy Pharmaceuticals, Inc. (SGYP) - The Independent Republic (NASDAQ:SGYP)
theindependentrepublic.com - September 26 at 7:19 PM
finance.yahoo.com logoJohn Paulson Trims Synergy (NASDAQ:SGYP)
finance.yahoo.com - September 23 at 6:44 PM
publicnow.com logoSynergy Pharmaceuticals to Present at OctoberINVESTfest 2016 (NASDAQ:SGYP)
www.publicnow.com - September 23 at 11:58 AM
News IconSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Performance Analysis - Newburgh Press (NASDAQ:SGYP)
newburghpress.com - September 22 at 6:57 PM
News IconFirst Week of SGYP November 18th Options Trading (NASDAQ:SGYP)
www.stockoptionschannel.com - September 20 at 12:35 PM
News IconSynergy Pharmaceuticals Inc. (NASDAQ: SGYP) Buy Rating ... - BNB Daily (blog) (NASDAQ:SGYP)
www.baseball-news-blog.com - September 19 at 7:11 PM
News IconHC Stocks in the Rumor! Aerie Pharmaceuticals Inc (AERI), Synergy Pharmaceuticals Inc (NASDAQ:SGYP) - share market updates (press release) (NASDAQ:SGYP)
sharemarketupdates.com - September 19 at 11:49 AM
thecountrycaller.com logoSynergy Pharmaceuticals Inc (SGYP) Has Over 97% Upside Potential; Here's Why - TCC (NASDAQ:SGYP)
www.thecountrycaller.com - September 19 at 11:49 AM
thecountrycaller.com logoSynergy Pharmaceuticals Inc (SGYP) Has Over 97% Upside Potential; Here's Why (NASDAQ:SGYP)
www.thecountrycaller.com - September 19 at 11:49 AM
smarteranalyst.com logoBTIG Bullish on Synergy Pharmaceuticals, Inc. (SGYP) Ahead of ... - Smarter Analyst (NASDAQ:SGYP)
www.smarteranalyst.com - September 17 at 11:43 AM
News IconSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Quarterly EPS Review - Newburg Press (NASDAQ:SGYP)
newburghpress.com - September 16 at 7:01 PM
News IconVery Good Day for the Indices (NASDAQ:SGYP)
www.fxstreet.com - September 16 at 7:01 PM
News IconHC Stocks Reports= Synergy Pharmaceuticals Inc (SGYP), Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NASDAQ:SGYP)
sharemarketupdates.com - September 16 at 10:49 AM
News IconSynergy Pharmaceuticals Inc(NASDAQ:SGYP) Upward Trend - Live Trading News (NASDAQ:SGYP)
www.livetradingnews.com - September 16 at 10:49 AM
investorplace.com logoSynergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch - Investorplace.com (NASDAQ:SGYP)
investorplace.com - September 16 at 10:49 AM
investorplace.com logoSynergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch (NASDAQ:SGYP)
investorplace.com - September 15 at 1:10 PM
4-traders.com logoNovo Nordisk A/S : Drug Makers Stocks Technical Reports -- Pernix Therapeutics, Synergy Pharma, Novo Nordisk, and Apricus Biosciences (NASDAQ:SGYP)
www.4-traders.com - September 15 at 10:54 AM
thestreet.com logoHere's a Reason Why Synergy Pharma (SGYP) Stock Is Rallying Today (NASDAQ:SGYP)
www.thestreet.com - September 14 at 7:25 PM
capitalcube.com logoSynergy Pharmaceuticals, Inc. :SGYP-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016 (NASDAQ:SGYP)
www.capitalcube.com - September 14 at 11:39 AM
thestreet.com logoInteresting SGYP Put And Call Options For January 2019 (NASDAQ:SGYP)
www.thestreet.com - September 12 at 12:02 PM
smarteranalyst.com logoRodman & Renshaw Chimes in on Synergy Pharmaceuticals Inc ... - Smarter Analyst (NASDAQ:SGYP)
www.smarteranalyst.com - September 9 at 12:01 PM
finance.yahoo.com logoSynergy Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference (NASDAQ:SGYP)
finance.yahoo.com - September 7 at 10:57 AM
News IconSynergy Pharmaceuticals, Inc.'s (SGYP): Traders Limelight - Hot Stocks Point (NASDAQ:SGYP)
www.hotstockspoint.com - September 1 at 10:29 AM
News IconKeep an eye on Active stock of Yesterday- Synergy Pharmaceuticals, Inc.'s (SGYP) - Hot Stocks Point (NASDAQ:SGYP)
www.hotstockspoint.com - August 30 at 10:37 AM
News IconHC Stocks Highlights: Synergy Pharmaceuticals Inc (SGYP), Hologic, Inc. (HOLX) - share market updates (press release) (NASDAQ:SGYP)
sharemarketupdates.com - August 25 at 7:36 PM
News IconSynergy Pharmaceuticals, Inc.'s (SGYP): Reviewing Hot Stock of Yesterday - Hot Stocks Point (NASDAQ:SGYP)
www.hotstockspoint.com - August 25 at 12:31 PM
istreetwire.com logoTrader's Round Up: Synergy Pharmaceuticals, Inc. (SGYP), Sabre ... - iStreetWire (NASDAQ:SGYP)
istreetwire.com - August 23 at 7:31 PM
thestreet.com logoSGYP April 2017 Options Begin Trading (NASDAQ:SGYP)
www.thestreet.com - August 22 at 11:57 AM
istreetwire.com logoTraders Recap: Exxon Mobil Corporation (XOM), Synergy Pharmaceuticals, Inc. (SGYP), The Home Depot, Inc. (HD) - iStreetWire (NASDAQ:SGYP)
istreetwire.com - August 16 at 7:29 PM
investorplace.com logoSynergy Pharmaceuticals Inc (SGYP): A Small-Cap Biotech With Momo On Its Side (NASDAQ:SGYP)
investorplace.com - August 15 at 12:33 PM
News IconHC Stocks Growth: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Allergan plc Ordinary Shares (NYSE:AGN) - share market updates (press release) (NASDAQ:SGYP)
sharemarketupdates.com - August 10 at 10:33 AM
News IconMost Volatile DrugMakers- MEI Pharma (NASDAQ:MEIP), Synergy Pharmaceuticals (NASDAQ:SGYP) - Seneca Globe (NASDAQ:SGYP)
www.senecaglobe.com - August 10 at 10:33 AM
streetupdates.com logoTwo Movers within Analysts Observation: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , Ionis Pharmaceuticals Inc ... - Street Updates (NASDAQ:SGYP)
www.streetupdates.com - August 10 at 10:33 AM
News IconActivision Blizzard, (NASDAQ:ATVI) & Synergy Pharmaceuticals (NASDAQ:SGYP) Eye-Catching Stocks - Money News (press release) (NASDAQ:SGYP)
www.newsismoney.com - August 10 at 10:33 AM
streetupdates.com logoAnalysts Ranking Previews: Aratana Therapeutics, Inc. (NASDAQ:PETX) , Synergy Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:SGYP)
www.streetupdates.com - August 10 at 10:33 AM
fortune.com logoSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Insiders Look Pessimistic About Prospects - Review Fortune (NASDAQ:SGYP)
reviewfortune.com - August 10 at 10:33 AM
News IconRevenue Estimates Analysis: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle (NASDAQ:SGYP)
www.newsoracle.com - August 10 at 10:33 AM
streetinsider.com logoSynergy Pharma (SGYP) Posts Q2 Loss of $0.23/Share (NASDAQ:SGYP)
www.streetinsider.com - August 8 at 7:36 PM
News IconSynergy Pharmaceuticals Reports Second Quarter 2016 Financial Results and Business Update (NASDAQ:SGYP)
ih.advfn.com - August 8 at 7:36 PM
4-traders.com logoSynergy Pharmaceuticals : Pharma reports 2Q loss (NASDAQ:SGYP)
www.4-traders.com - August 8 at 7:36 PM
sg.finance.yahoo.com logoSynergy Pharma reports 2Q loss (NASDAQ:SGYP)
sg.finance.yahoo.com - August 8 at 7:36 PM
equities.com logoSynergy Pharmaceuticals Inc. (SGYP) Jumps 8.06% on August 05 - Equities.com (NASDAQ:SGYP)
www.equities.com - August 6 at 10:04 AM
streetupdates.com logoAnalysts Rating Overview: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates (NASDAQ:SGYP)
www.streetupdates.com - August 5 at 10:25 AM
streetupdates.com logoStock's Ratings to Focus: CVS Health Corporation (NYSE:CVS) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates (NASDAQ:SGYP)
www.streetupdates.com - August 4 at 7:51 PM
fortune.com logoSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Stock Rises, Analysts: Buy Rating - Review Fortune (NASDAQ:SGYP)
reviewfortune.com - August 2 at 7:44 PM

Social

Synergy Pharmaceuticals (NASDAQ:SGYP) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff